We advised the shareholders of the Tuttlingen, Germany, based NORMED Medizin-Technik GmbH on a cross border sale of all shares to Zimmer Holdings, Inc., a world leader in musculoskeletal health solutions.
Blue Corporate Finance has managed the transaction process, has advised the vendors within all phases of the negotiations and has supported the management of NORMED, during purchasers Due Diligence.
NORMED Medizin-Technik GmbH, founded in 1988 and based in Tuttlingen, Germany, is an innovative medical company that develops, produces and globally markets a broad range of implants and specialized instruments for foot and ankle and hand and wrist surgeries.
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmers 2012 sales were approximately USD 4.5 billion. The Company is supported by the efforts of more than 8,500 employees worldwide.
“We have been well represented by Blue Corporate Finance throughout the entire transaction. It was a very pleasant and professional cooperation and we will recommend Blue Corporate Finance at any time.”
Founder and shareholder of NORMED Medizin-Technik GmbH
December 20, 2018
Quarton International advises evitria in its sale to AFINUM and SHS
To subscribe to our Newsletter, please use the following link.